{"id":561524,"date":"2026-07-04T03:00:00","date_gmt":"2026-07-04T01:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/lo-studio-di-fase-iii-sulla-terapia-a-durata-limitata-con-bepirovirsi-ha-avuto-esito-positivo\/"},"modified":"2026-07-04T03:00:00","modified_gmt":"2026-07-04T01:00:00","slug":"lo-studio-di-fase-iii-sulla-terapia-a-durata-limitata-con-bepirovirsi-ha-avuto-esito-positivo","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/it\/lo-studio-di-fase-iii-sulla-terapia-a-durata-limitata-con-bepirovirsi-ha-avuto-esito-positivo\/","title":{"rendered":"Lo studio di fase III sulla terapia a durata limitata con bepirovirsi ha avuto esito positivo"},"content":{"rendered":"<p>... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Flo-studio-di-fase-iii-sulla-terapia-a-durata-limitata-con-bepirovirsi-ha-avuto-esito-positivo%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>&#8230; Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich Jetzt beitretenAlready a member? Accedi... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Flo-studio-di-fase-iii-sulla-terapia-a-durata-limitata-con-bepirovirsi-ha-avuto-esito-positivo%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":561525,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Epatite B cronica: una cura all\u2019orizzonte?  ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11550,11415,11306,11522,11515],"tags":[98679,98676,15941,15593,24787,77856,15589,13618,98685,98682,98680,58634],"powerkit_post_featured":[],"class_list":["post-561524","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-it","category-infettivologia","category-medicina-interna-generale","category-rapporti-del-congresso","category-studi","tag-b-well","tag-bepirovirsen","tag-carcinoma-epatocellulare","tag-cirrosi-epatica","tag-epatite-b","tag-epatite-virale","tag-hbv-it","tag-hcc-it","tag-infezione-da-hbv-non-cirrotica","tag-oligonucleotide-antisenso","tag-programma-di-studi","tag-studio-di-fase-iii","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-08-04 00:20:11","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"it_IT","wpml_translations":{"pt_PT":{"locale":"pt_PT","id":561529,"slug":"o-ensaio-clinico-de-fase-iii-sobre-a-terapia-de-duracao-limitada-com-bepirovirsen-decorreu-com-sucesso","post_title":"O ensaio cl\u00ednico de Fase III sobre a terapia de dura\u00e7\u00e3o limitada com bepirovirsen decorreu com sucesso","href":"https:\/\/medizinonline.com\/pt-pt\/o-ensaio-clinico-de-fase-iii-sobre-a-terapia-de-duracao-limitada-com-bepirovirsen-decorreu-com-sucesso\/"},"es_ES":{"locale":"es_ES","id":561539,"slug":"el-ensayo-de-fase-iii-sobre-el-tratamiento-de-duracion-limitada-con-bepirovirsen-ha-tenido-un-resultado-satisfactorio","post_title":"El ensayo de fase III sobre el tratamiento de duraci\u00f3n limitada con bepirovirsen ha tenido un resultado satisfactorio","href":"https:\/\/medizinonline.com\/es\/el-ensayo-de-fase-iii-sobre-el-tratamiento-de-duracion-limitada-con-bepirovirsen-ha-tenido-un-resultado-satisfactorio\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/561524","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/comments?post=561524"}],"version-history":[{"count":0,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/561524\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media\/561525"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media?parent=561524"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/category?post=561524"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/tags?post=561524"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/powerkit_post_featured?post=561524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}